FDA tells vaccine makers to update boosters to target omicron subvariants
Jun 30, 2022
Pfizer and Moderna are expected to start producing reformulated doses this summer.
FDA panel supports rollout of tweaked booster shots from Moderna, Pfizer this fall
Jun 29, 2022
The advisory panel approval speeds the process by which FDA regulators will push for updated booster formulations.
Pfizer has two updated booster shots to help fight omicron
Jun 27, 2022
The company said Saturday that it was confident that its new booster candidates are better than their predecessor.
FDA panel to weigh improved booster shots from Moderna, Pfizer
Jun 27, 2022
Both Pfizer and Moderna have been testing updated booster shots that target the omicron variant.
Fourth dose of BNT162b2 prevents severe COVID-19 in nursing home residents
Jun 27, 2022
Substantial protection against hospitalizations and deaths seen among nursing home residents during the omicron surge.
Moderna says omicron-specific booster should be ready by August
Jun 23, 2022
The vaccine targets both omicron and the original strain of the virus.
Exercise may boost immune response to flu vaccine
Jun 16, 2022
However, acute exercise does not show a benefit for generally inactive people.
COVID-19 vaccines cut mortality with heart failure
Jun 16, 2022
Those who are partially vaccinated and unvaccinated face the same increased risk, whereas boosted and fully vaccinated adults fare best.
Vaccine effectiveness against SARS-CoV-2 infection wanes over time
Jun 14, 2022
However, for all ages, vaccine effectiveness against severe COVID-19 was high overall, at 90% five months or longer after two doses.
Durability of mRNA-1273 protection against symptomatic COVID-19 examined
Jun 13, 2022
Among those receiving two doses of the Moderna vaccine, peak vaccine efficacy against symptomatic COVID-19 was estimated to be 94.1% at 120 days after the first dose.